These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4957850)

  • 1. Morphologic observations on the effect of antimalarial agents on the erythrocytic forms of Plasmodium berghei in vitro.
    Ladda RL
    Mil Med; 1966 Sep; 131(9):Suppl:993-1008. PubMed ID: 4957850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphology of the strains of Plasmodium berghei berghei with "acquired" resistance to antimalarial drugs of different chemical groups. I. Morphologic features of strains resistant to derivatives of 4-aminoquinoline and diaminopyrimidine].
    Rabinovich SA
    Med Parazitol (Mosk); 1969; 38(3):287-94. PubMed ID: 5396562
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the effect of antimalarial drugs against erythrocytic forms of Plasmodium gallinaceum in vitro.
    JOSEPHSON ES; TAYLOR DJ; GREENBERG J; COATNEY GR
    J Infect Dis; 1953; 93(3):257-62. PubMed ID: 13109240
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative cytochemical study of erythrocytic stages of Plasmodium lophurae Plasmodium berghei.
    Ahr GF
    Mil Med; 1966 Sep; 131(9):Suppl:1064-70. PubMed ID: 4957812
    [No Abstract]   [Full Text] [Related]  

  • 5. An in vitro system for screening potential antimalarial drugs.
    Canfield CJ; Altstatt LB; Elliot VB
    Am J Trop Med Hyg; 1970 Nov; 19(6):905-9. PubMed ID: 4992725
    [No Abstract]   [Full Text] [Related]  

  • 6. The chemotherapy of rodent malaria. 13. Fine structural changes observed in the eryhrocytic stages of Plasmodium berghei berghei following exposureto primaquine and menoctone.
    Howells RE; Pters W; Fullard J
    Ann Trop Med Parasitol; 1970 Jun; 64(2):203-7. PubMed ID: 5491874
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroquine and dihydroquinine. In vitro studies by their antimalarial effect upon Plasmodium knowlesi.
    Polet H; Barr CF
    J Pharmacol Exp Ther; 1968 Dec; 164(2):380-6. PubMed ID: 4972437
    [No Abstract]   [Full Text] [Related]  

  • 8. The study of antimalarial compounds in vitro.
    Richards WH; Williams SG
    Br J Pharmacol; 1970 May; 39(1):237P. PubMed ID: 5420128
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
    J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated erythrocytic forms of Plasmodium berghei. An electron-microscopical study.
    Killby VA; Silverman PH
    Am J Trop Med Hyg; 1969 Nov; 18(6):836-59. PubMed ID: 5355235
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the turkey.
    ROSSAN RN
    Exp Parasitol; 1957 Mar; 6(2):163-88. PubMed ID: 13414813
    [No Abstract]   [Full Text] [Related]  

  • 12. Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium.
    Moles E; Fernàndez-Busquets X
    Future Med Chem; 2015; 7(7):837-40. PubMed ID: 26061102
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of Coptis teeta Wall. for antimalarial effect: a preliminary report.
    Sharma SK; Satyanarayana S; Yadav RN; Dutta LP
    Indian J Malariol; 1993 Sep; 30(3):179-81. PubMed ID: 8131885
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E
    Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design of original antimalarial drugs. An example of phospholipid metabolism.
    Vial HJ; Ancelin ML; Elabbadi N; Gumila C; Bonnet H; Jeong YH; Philippot J; Calas M; Portefaix P; Piquet G
    Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of piperaquine on the fine structure of the erythrocytic stages of Plasmodium berghei ANKA strain].
    Chen L; Qian YL; Li ZL; Zhang KH; Dai BQ; Liu ZF; Wang JL
    Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):351-3. PubMed ID: 2954398
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a new chemical class of antimalarials.
    Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
    J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.